INTRODUCTION: Array comparative genomic hybridisation (array CGH) is a powerful method that detects alteration of gene copy number with greater resolution and efficiency than traditional methods. However, its ability to detect disease causing duplications in constitutional genomic DNA has not been shown. We developed an array CGH assay for X linked hypopituitarism, which is associated with duplication of Xq26-q27. METHODS: We generated custom BAC/PAC arrays that spanned the 7.3 Mb critical region at Xq26.1-q27.3, and used them to search for duplications in three previously uncharacterised families with X linked hypopituitarism. RESULTS: Validation experiments clearly identified Xq26-q27 duplications that we had previously mapped by fluorescence in situ hybridisation. Array CGH analysis of novel XH families identified three different Xq26-q27 duplications, which together refine the critical region to a 3.9 Mb interval at Xq27.2-q27.3. Expression analysis of six orthologous mouse genes from this region revealed that the transcription factor Sox3 is expressed at 11.5 and 12.5 days after conception in the infundibulum of the developing pituitary and the presumptive hypothalamus. DISCUSSION: Array CGH is a robust and sensitive method for identifying X chromosome duplications. The existence of different, overlapping Xq duplications in five kindreds indicates that X linked hypopituitarism is caused by increased gene dosage. Interestingly, all X linked hypopituitarism duplications contain SOX3. As mutation of this gene in human beings and mice results in hypopituitarism, we hypothesise that increased dosage of Sox3 causes perturbation of pituitary and hypothalamic development and may be the causative mechanism for X linked hypopituitarism.
INTRODUCTION: Array comparative genomic hybridisation (array CGH) is a powerful method that detects alteration of gene copy number with greater resolution and efficiency than traditional methods. However, its ability to detect disease causing duplications in constitutional genomic DNA has not been shown. We developed an array CGH assay for X linked hypopituitarism, which is associated with duplication of Xq26-q27. METHODS: We generated custom BAC/PAC arrays that spanned the 7.3 Mb critical region at Xq26.1-q27.3, and used them to search for duplications in three previously uncharacterised families with X linked hypopituitarism. RESULTS: Validation experiments clearly identified Xq26-q27 duplications that we had previously mapped by fluorescence in situ hybridisation. Array CGH analysis of novel XH families identified three different Xq26-q27 duplications, which together refine the critical region to a 3.9 Mb interval at Xq27.2-q27.3. Expression analysis of six orthologous mouse genes from this region revealed that the transcription factor Sox3 is expressed at 11.5 and 12.5 days after conception in the infundibulum of the developing pituitary and the presumptive hypothalamus. DISCUSSION: Array CGH is a robust and sensitive method for identifying X chromosome duplications. The existence of different, overlapping Xq duplications in five kindreds indicates that X linked hypopituitarism is caused by increased gene dosage. Interestingly, all X linked hypopituitarism duplications contain SOX3. As mutation of this gene in human beings and mice results in hypopituitarism, we hypothesise that increased dosage of Sox3 causes perturbation of pituitary and hypothalamic development and may be the causative mechanism for X linked hypopituitarism.
Authors: S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter Journal: Genes Chromosomes Cancer Date: 1997-12 Impact factor: 5.006
Authors: J Collignon; S Sockanathan; A Hacker; M Cohen-Tannoudji; D Norris; S Rastan; M Stevanovic; P N Goodfellow; R Lovell-Badge Journal: Development Date: 1996-02 Impact factor: 6.868
Authors: D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson Journal: Nat Genet Date: 1998-10 Impact factor: 38.330
Authors: Patrick G Buckley; Kiran K Mantripragada; Magdalena Benetkiewicz; Isabel Tapia-Páez; Teresita Diaz De Ståhl; Magnus Rosenquist; Haider Ali; Caroline Jarbo; Cecilía De Bustos; Carina Hirvelä; Birgitta Sinder Wilén; Ingegerd Fransson; Charlotte Thyr; Britt-Inger Johnsson; Carl E G Bruder; Uwe Menzel; Martin Hergersberg; Nils Mandahl; Elisabeth Blennow; Anna Wedell; David M Beare; John E Collins; Ian Dunham; Donna Albertson; Daniel Pinkel; Boris C Bastian; A Fawad Faruqi; Roger S Lasken; Koichi Ichimura; V Peter Collins; Jan P Dumanski Journal: Hum Mol Genet Date: 2002-12-01 Impact factor: 6.150
Authors: Nicola M Solomon; Shelley A Ross; Susan M Forrest; Paul Q Thomas; Thomas Morgan; Joseph L Belsky; Frans A Hol; Pamela S Karnes; Nancy J Hopwood; Susan E Myers; Anjanette S Tan; Garry L Warne Journal: J Med Genet Date: 2007-04 Impact factor: 6.318
Authors: Natalay Kouprina; Nicholas C O Lee; Adam Pavlicek; Alexander Samoshkin; Jung-Hyun Kim; Hee-Sheung Lee; Sudhir Varma; William C Reinhold; John Otstot; Greg Solomon; Sean Davis; Paul S Meltzer; Johanna Schleutker; Vladimir Larionov Journal: Genes Chromosomes Cancer Date: 2012-06-26 Impact factor: 5.006
Authors: Mary Anne Potok; Kelly B Cha; Andrea Hunt; Michelle L Brinkmeier; Michael Leitges; Andreas Kispert; Sally A Camper Journal: Dev Dyn Date: 2008-04 Impact factor: 3.780